Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Annual Meeting 2020

Annual Meeting 2020

Annual Meeting Materials

 

 

The Annual Meeting of Shareholders of Charles River Laboratories International, Inc. will be held:

Wednesday, May 6, 2020 at 8:00 a.m.
Charles River Laboratories International, Inc.
251 Ballardvale Street
Wilmington, Massachusetts 01887

Before you vote, you should carefully review our 2020 Proxy Statement, Form 10-K for fiscal year 2019, 2019 Annual Report, and related materials that were mailed on or around March 26, 2020, to shareholders of record as of March 16, 2020. For your convenience, these materials may be viewed by selecting the links below:

To view these documents, you will need Adobe Acrobat; click here for detailed download instructions.

Related Links

Corporate Governance  |  SEC Filings  |  Contact Information

Featured Report

2019 Annual Report (PDF)